The Future of Fashion Magazines

Nike's Supply Chain Woes, Twice Toothpaste Launches in Target

ADVERTISEMENT

WHAT YOU NEED TO KNOW TODAY: MONDAY, MARCH 21, 2022 Even as titles like InStyle shutter their print edition, value can still be found in the format. Twice, a direct-to-consumer toothpaste brand co-founded by Lenny Kravitz, is launching in Target at a time when more brands are blurring the line between oral care and beauty. Nike continues to battle supply chain problems, but is finding ways to use the disruptions to its advantage. BoF Professional analysis now unlocked for non-members: High-end watchmakers eyeing virtual goods see promise as well as philosophical and legal challenges.

TOP STORIES

MEDIA A Survival Strategy for Fashion Magazines By Alexandra Mondalek

InStyle, Glamour and other titles are going online-only, but brands and publishers say the glossy format still has a role to play in telling stories — and driving revenue. READ MORE

BEAUTY DTC Toothpaste Brand Twice Inks New Retail Partnerships By Diana Pearl

Twice, which is co-founded by Lenny Kravitz, is betting that the 'oral beauty' boom will primarily occur offline. READ MORE

RETAIL Supply Chain Woes Accelerate Change at Nike By Brian Baskin This week, everyone will be talking about Nike's latest results and Ralph Lauren's first in-person show since 2019. READ MORE

Luxury Watch NFTs: Opportunity or Headache? READ MORE

BoF PROFESSIONAL Join now and enjoy your first 30 days for just $/£/€1 START TRIAL

SPECIAL FEATURE

BoF Insights: Building Resilience and Value in Fashion's Supply chain BoF's guide to transforming supply chains into a competitive advantage — understand market shifts, navigate pandemic and geopolitical challenges and lay the groundwork for a stronger future. To explore the full report click here. BUY NOW

The Business of Fashion AGENDA-SETTING INTELLIGENCE, ANALYSIS AND ADVICE FOR THE GLOBAL FASHION COMMUNITY. CONNECT WITH US ON CONTACT US ETHICS POLICY SPONSORSHIP & ADVERTISING JOB OPPORTUNITIES This email was sent to edwardlorilla1986.paxforex@blogger.com Update your preferences or unsubscribe from this list. All services provided are subject to our Privacy Policy. The Business of Fashion Ltd The Business of Fashion, Soho Works 2, Television Centre, 101 Wood Lane, London, W12 7FR, United Kingdom businessoffashion.com

Our # 1 Biotech Stock for March

March 21, 2022     Here is an interesting offer from our partners: Our # 1 Biotech Stock for March Dear Investor,   On September 10, 2018, a tiny Cambridge biotech firm won a patent on a new kind of genetic software that can "Cut & Paste" any disease from your body.   This revolutionary new kind of treatment will not just change medicine -   It has the potential to eliminate genetic disease from our species.   If that sounds like science fiction, consider this - The Nobel Prize Committee is calling it "The Holy Grail of Medicine" The Wall Street Journal reports the company is "transforming medicine." 60 Minutes reports the company is "revolutionizing the search for new drugs." And the biggest drug companies have rushed to invest over a $1 billion in the past year alone -   Juno Pharma invested $700 million.   Glaxo SmithKline invested $350 million.   Johnson and Johnson invested $292 million.   That's on top of the $120 million Bill Gates and Google Ventures already invested into this.   The list goes on and on...   Never before has so much money invested in a new treatment so quickly.   And because of that, it's going to create more millionaires than any other single breakthrough in history. More than the internet, more than computers, more than cars.   Investor's Business Daily estimates the market is worth at least $75 billion market.   But right now, its stock price is just a tiny fraction of that size.   Our research proves that anyone who gets in today could make 46,751%!   That's if the company doesn't get taken over for fast 300% gains first.   CLICK HERE to see how you can profit from this rare opportunity>>>   Sincerely, "The Buck Stops Here" Dylan Jovine CEO and Founder Behind the Markets This third party offer is brought to you by Emerging Shares. 152 City Road, London, EC1V 2NX. If you would like to unsubscribe from receiving offers, click here. To unsubscribe globally from all of our brands and newsletters, click here. Please Read Our Privacy Policy To ensure you receive our emails, be sure to whitelist us. Unsubscribe | View In Browser © Copyright 2022. All Rights Reserved.